These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22048011)

  • 1. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.
    Dickerson F; Stallings C; Origoni A; Boronow J; Yolken R
    Schizophr Res; 2007 Jul; 93(1-3):261-5. PubMed ID: 17490859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.
    Yolken RH; Torrey EF; Lieberman JA; Yang S; Dickerson FB
    Schizophr Res; 2011 May; 128(1-3):61-5. PubMed ID: 21353483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Ruslanova I; Yolken RH
    Arch Gen Psychiatry; 2003 May; 60(5):466-72. PubMed ID: 12742867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.
    Dickerson F; Stallings C; Sullens A; Origoni A; Leister F; Krivogorsky B; Yolken R
    Brain Behav Immun; 2008 Oct; 22(7):1103-1107. PubMed ID: 18571372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    J Affect Disord; 2013 Sep; 150(2):456-9. PubMed ID: 23684514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Krivogorsky B; Yolken RH
    Biol Psychiatry; 2004 Mar; 55(6):588-93. PubMed ID: 15013827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
    Dickerson F; Schroeder J; Stallings C; Origoni A; Katsafanas E; Schwienfurth LA; Savage CL; Khushalani S; Yolken R
    Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia.
    Schretlen DJ; Vannorsdall TD; Winicki JM; Mushtaq Y; Hikida T; Sawa A; Yolken RH; Dickerson FB; Cascella NG
    Schizophr Res; 2010 May; 118(1-3):224-31. PubMed ID: 20153952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study.
    Fruchter E; Goldberg S; Fenchel D; Grotto I; Ginat K; Weiser M
    Schizophr Res; 2015 Oct; 168(1-2):292-6. PubMed ID: 26362735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cognitive impairment in HSV-1 positive schizophrenia and bipolar patients: Systematic review and meta-analysis.
    Tucker JD; Bertke AS
    Schizophr Res; 2019 Jul; 209():40-47. PubMed ID: 30639164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
    J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to herpes simplex virus, type 1 and reduced cognitive function.
    Thomas P; Bhatia T; Gauba D; Wood J; Long C; Prasad K; Dickerson FB; Gur RE; Gur RC; Yolken RH; Nimgaonkar VL; Deshpande SN
    J Psychiatr Res; 2013 Nov; 47(11):1680-5. PubMed ID: 23920011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis.
    Dickerson F; Schroeder JR; Nimgaonkar V; Gold J; Yolken R
    Psychiatry Res; 2020 Sep; 291():113157. PubMed ID: 32593064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.
    Shirts BH; Prasad KM; Pogue-Geile MF; Dickerson F; Yolken RH; Nimgaonkar VL
    Schizophr Res; 2008 Dec; 106(2-3):268-74. PubMed ID: 18801645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor.
    Gerber SI; Krienke UJ; Biedermann NC; Grunze H; Yolken RH; Dittmann S; Langosch JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):110-6. PubMed ID: 21945379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.
    Tedla Y; Shibre T; Ali O; Tadele G; Woldeamanuel Y; Asrat D; Aseffa A; Mihret W; Abebe M; Alem A; Medhin G; Habte A
    Ethiop Med J; 2011 Jul; 49(3):211-20. PubMed ID: 21991754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.